Teacher Retirement System of Texas raised its stake in Chemed Corp. (NYSE:CHE) by 13.9% during the second quarter, according to its most recent filing with the SEC. The fund owned 2,362 shares of the company’s stock after buying an additional 288 shares during the period. Teacher Retirement System of Texas’ holdings in Chemed Corp. were worth $322,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Invictus RG boosted its stake in shares of Chemed Corp. by 215.1% in the first quarter. Invictus RG now owns 2,893 shares of the company’s stock valued at $392,000 after buying an additional 1,975 shares during the period. AMP Capital Investors Ltd boosted its stake in shares of Chemed Corp. by 83.3% in the first quarter. AMP Capital Investors Ltd now owns 4,400 shares of the company’s stock valued at $598,000 after buying an additional 2,000 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Chemed Corp. by 72.3% in the first quarter. Renaissance Technologies LLC now owns 148,200 shares of the company’s stock valued at $20,074,000 after buying an additional 62,200 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Chemed Corp. by 10.7% in the first quarter. Goldman Sachs Group Inc. now owns 48,053 shares of the company’s stock valued at $6,509,000 after buying an additional 4,640 shares during the period. Finally, Quadrature Capital Ltd acquired a new stake in shares of Chemed Corp. during the first quarter valued at approximately $387,000. Hedge funds and other institutional investors own 98.64% of the company’s stock.
Chemed Corp. (NYSE:CHE) opened at 140.57 on Friday. Chemed Corp. has a 1-year low of $124.77 and a 1-year high of $160.12. The firm’s 50-day moving average price is $138.63 and its 200 day moving average price is $136.21. The stock has a market cap of $2.28 billion, a PE ratio of 22.30 and a beta of 1.17.
Chemed Corp. (NYSE:CHE) last announced its earnings results on Monday, July 25th. The company reported $1.80 EPS for the quarter, topping the consensus estimate of $1.72 by $0.08. The company had revenue of $290 million for the quarter, compared to analysts’ expectations of $393.50 million. Chemed Corp. had a return on equity of 24.12% and a net margin of 6.93%. The business’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.71 earnings per share. Equities research analysts expect that Chemed Corp. will post $7.25 EPS for the current year.
Several equities research analysts have commented on the stock. RBC Capital Markets reiterated a “sector perform” rating and issued a $162.00 price target (up from $136.00) on shares of Chemed Corp. in a research report on Wednesday, July 27th. Royal Bank Of Canada boosted their price target on shares of Chemed Corp. from $136.00 to $162.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 27th. Zacks Investment Research raised Chemed Corp. from a “hold” rating to a “buy” rating and set a $167.00 price target on the stock in a research note on Thursday, July 28th. Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $155.00 price target on shares of Chemed Corp. in a research note on Tuesday, September 27th. Finally, JMP Securities reissued a “hold” rating on shares of Chemed Corp. in a research note on Sunday, September 4th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Chemed Corp. presently has a consensus rating of “Hold” and a consensus target price of $161.50.
In other news, VP Arthur V. Tucker, Jr. sold 3,089 shares of the company’s stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $143.88, for a total transaction of $444,445.32. Following the transaction, the vice president now owns 3,234 shares of the company’s stock, valued at $465,307.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Kevin J. Mcnamara sold 18,000 shares of the company’s stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $144.87, for a total value of $2,607,660.00. Following the transaction, the insider now directly owns 163,266 shares in the company, valued at approximately $23,652,345.42. The disclosure for this sale can be found here. Insiders own 5.32% of the company’s stock.
Chemed Corp. Company Profile
Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.